Hrs inhibits citron kinase-mediated HIV-1 budding via its FYVE domain by Ding, Jiwei et al.
COMMUNICATION
Hrs inhibits citron kinase-mediated HIV-1
budding via its FYVE domain
Jiwei Ding1,2, Lishan Su3, Guangxia Gao1✉
1 Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
2 Graduate University of Chinese Academy of Sciences, Beijing 100039, China
3 The University of North Carolina, Chapel Hill, NC 27599-7295, USA
✉ Correspondence: gaogx@moon.ibp.ac.cn
Received April 8, 2011 Accepted May 12, 2011
ABSTRACT
Hepatocyte growth factor-regulated tyrosine kinase sub-
strate (Hrs) is a key component of the endosomal sorting
complexes required for transport and has been demon-
strated to play a regulatory role in endocytosis/exocy-
tosis and the accumulation of internal vesicles in
multivesicular bodies. Citron kinase is a Ser/The kinase
that we previously reported to enhance human immuno-
deficiency virus type 1 (HIV-1) virion production. How-
ever, the relationship between Hrs and citron kinase in
HIV-1 production remains elusive. Here, we report that
Hrs interacts with citron kinase via its FYVE domain.
Overexpression of Hrs or the FYVE domain resulted in a
significant decrease in HIV-1 virion production. Depletion
of Hrs by RNA interference in HEK293T cells increased
HIV-1 virion production and enhanced the activity of
citron kinase. These data suggest that Hrs inhibits HIV-1
production by inhibiting citron kinase-mediated exocy-
tosis.
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INTRODUCTION
Viral particle budding is a key step in the life cycle of human
immunodeficiency virus type 1 (HIV-1) replication. HIV-1
structural protein Pr55Gag can direct virion assembly and
budding in the absence of other HIV-1 viral proteins. HIV-1
Gag is composed of four distinct domains: the matrix (MA),
capsid (CA), nucleocapsid (NC), and late (L) domains. The N-
terminus of the MA domain contains a series of basic amino
acids, which are required for the interaction with acidic
phospholipids, and a myristyl group (Paillart and Gottlinger,
1999), which is believed to facilitate Gag targeting to
membranes (Zhou and Resh, 1996; Spearman et al., 1997;
Tang et al., 2004). The L domain catalyzes the pinching of
viral particles from the cell surface (VerPlank et al., 2001;
Bouamr et al., 2003; Strack et al., 2003). The PAT/SP and
YPXL tetrapeptide motifs in the L domain of HIV-1 Gag, which
interact with tsg101 and Alix, respectively, are required for
viral budding (VerPlank et al., 2001; Pornillos et al., 2002;
Strack et al., 2003; Zhai et al., 2008). HIV-1 facilitates its
budding through the endosomal sorting complexes required
for transport (ESCRTs), which include ESCRT 0, ESCRT I,
ESCRT II, and ESCRT III. ESCRTcomplexes are sequentially
recruited to budding sites to facilitate viral budding, with
ESCRT III ultimately dissociated by the VSP4 ATPase
(Stuchell-Brereton et al., 2007; McCullough et al., 2008).
Hepatocyte growth factor-regulated tyrosine kinase sub-
strate (Hrs) was first identified as a protein that is phosphory-
lated in response to hepatocyte growth factor. The N-terminal
region of Hrs contains VHS and FYVE domains, and the C-
terminal region contains a glutamine/proline-rich domain. The
FYVE domain (which shares a conserved sequence with
Fab1, YOTB, Vac1, and EEA1) is a small, cysteine-rich
domain that binds to two zinc ions. FYVE domain-containing
proteins have diverse biological functions, including endocy-
tic transport, regulation of endosomal membrane fusion, and
signal transduction (Mills et al., 1998; Simonsen et al., 1998).
Hrs contains four PXXP motifs that potentially interact with
SH3-containing proteins and a PPXY motif that is the putative
binding site for WW-domain (Kwong et al., 2000). In addition,
Hrs contains a ubiquitin-interacting motif (UIM), which is
presumed to bind to various ubiquitinated proteins (Pridgeon
et al., 2009).
Hrs interacts with tsg101, which further recruits other
ESCRT I subunits, as well as the ESCRT II and ESCRT III
470 © Higher Education Press and Springer-Verlag Berlin Heidelberg 2011
Protein Cell 2011, 2(6): 470–476
DOI 10.1007/s13238-011-1053-y
Protein & Cell
complexes (Bache et al., 2003). The C-terminal portion of Hrs
alone interacts with tsg101 and interferes with HIV-1 Gag
particle production (Bouamr et al., 2007). However, the
mechanism by which Hrs suppresses HIV-1 virion production
remains unclear.
We previously reported that citron kinase, a Ser/The
kinase, co-localizes with HIV-1 Gag and enhances HIV-1
virion production (Loomis et al., 2006). Overexpression of
citron kinase increases HIV-1 virion production, whereas
knockdown of citron kinase reduces virion production. We
further mapped the third and fourth leucine zipper domains
RBD domain and the zinc finger domain to be the shortest
sequences required for HIV-1 production enhancement. In
the present study, we report that Hrs interacts with citron
kinase through its FYVE domain and inhibits citron kinase-
mediated enhancement of HIV-1 budding.
RESULTS
Citron kinase co-localizes with Hrs in the early endosome
We previously reported that citron kinase co-localizes with
HIV-1 Gag on the membrane of certain cytoplasmic compart-
ments (Loomis et al., 2006). There are several types of
cytoplasmic membrane organelles, including the early endo-
some, multivesicular bodies (MVBs), recycling endosome,
the late endosome, and lysosome. To determine whether
citron kinase is specifically located in any of these endo-
somes, it was co-expressed with the endosomal markers
FYVE-GFP (early endosome/MVB marker), EHD1-GFP
(recycling endosome marker), and Lamp-1-GFP (late endo-
some/lysosome marker), and the locations of citron kinase
and these markers were observed by confocal microscopy.
As shown in Fig. 1A–C, citron kinase displayed no obvious
co-localization with EHD1-GFP (Fig. 1A) or Lamp-1-GFP (Fig.
1C). In contrast, citron kinase did co-localize with FYVE-GFP
(Fig. 1B), indicating that citron kinase was located in the early
endosome/MVB.
The FYVE domain used above was derived from the Mus
musculus Hrs. To explore whether citron kinase co-localizes
with Hrs, myc-tagged citron kinase and FLAG-tagged Hrs
were co-expressed in HeLa cells and analyzed for co-
localization by immunostaining. The results demonstrate
that citron kinase partially co-localizes with Hrs (Fig. 1D).
To determine whether the Hrs FYVE domain is essential for
co-localization of citron kinase and Hrs, myc-tagged citron
kinase and HA-tagged HrsΔFYVE, in which the FYVE domain
was deleted, were co-expressed in HeLa cells and analyzed
for co-localization by immunostaining. We found that citron
kinase failed to co-localize with HrsΔFYVE (Fig. 1E),
suggesting that the FYVE domain is the binding module for
citron kinase and Hrs.
Hrs interacts with citron kinase via its FYVE domain
The above results suggest that citron kinase interacts with the
FYVE domain of Hrs. To test this possibility, FLAG-tagged Hrs
and myc-tagged citron kinase were co-expressed in
HEK293T cells, and the interaction between the two proteins
was assayed by co-immunoprecipitation. Indeed, immuno-
precipitation of citron kinase co-precipitated Hrs (Fig. 2A). To
further determine whether the FYVE domain alone interacts
with citron kinase, FYVE-GFP was co-expressed with citron
kinase in HEK293Tcells, and its interaction with citron kinase
was analyzed. As expected, immunoprecipitation of citron
kinase co-precipitated FYVE-GFP (Fig. 2B). These results
establish that citron kinase interacts with Hrs via its FYVE
domain.
Hrs inhibits citron kinase-mediated HIV-1 production
It has been reported that Hrs inhibits exocytosis and that
citron kinase enhances HIV-1 production by promoting
exocytosis. Considering the interaction between Hrs and
citron kinase, we analyzed the effect of Hrs on citron
kinase-mediated HIV-1 production. Full-length Hrs, the
FYVE domain of Hrs, and Hrs6FYVE were co-transfected
into HEK293T cells with HIV-1 vector-producing constructs in
the presence or absence of citron kinase. The HIV-1 vector,
which expresses a luciferase reporter, was harvested to
infect HeLa cells, and luciferase activity was measured in
both producer HEK293Tcells and recipient HeLa cells. It has
been reported that the expression of citron kinase or Hrs
affects the number of virions produced from cells without
changing the infectivity of the virions (Loomis et al., 2006;
Bouamr et al., 2007). Hence, the luciferase activity reflects
virus production. Here, the virus production efficiency is
presented as the luciferase activity in the recipient cells
divided by the normalized luciferase activity in the producer
cells. Overexpression of full-length Hrs, the FYVE domain of
Hrs, and Hrs6FYVE reduced HIV-1 production by
approximately 4.5-, 5.3-, and 3.0-fold, respectively (Fig. 3;
columns 3, 5 and 7). Consistent with our previous results,
overexpression of citron kinase increased HIV-1 production
by ~8-fold (Fig. 3; column 2). When citron kinase was
co-expressed with full-length Hrs or the Hrs FYVE domain,
the enhancement of HIV-1 production was significantly
compromised (Fig. 3; comparing column 2 with columns 4
and 6). In comparison, the effect of HrsΔFYVE on citron
kinase was much less significant (Fig. 3; column 8).
Together, these results indicate that Hrs inhibits citron
kinase-mediated HIV-1 production via its FYVE domain.
The residual inhibitory effect of HrsΔFYVE suggests that
Hrs may also inhibit HIV-1 production in a citron kinase-
independent manner.
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Figure 1. Citron kinase co-localizes with Hrs. HeLa cells were transfected with plasmids expressing myc-tagged citron kinase
(citK) and endosomal markers EHD1-GFP (A), FYVE-GFP (B) or Lamp-1-GFP (C). At 24 h post-transfection, the cells were
incubated with anti-myc antibody and then TRITC-conjugated secondary antibody. (D) HeLa cells expressing myc-tagged citron
kinase (citK) and Flag-tagged Hrs were stained with rabbit polyclonal anti-citron antibody and mouse monoclonal anti-Flag antibody,
and then FITC-conjugated goat anti-rabbit antibody and TRITC-conjugated anti-mouse antibody. (E) HeLa cells expressing myc-
tagged citron kinase (citK) and HA-tagged HrsdFYVEwere stained with rabbit polyclonal anti-citron antibody andmousemonoclonal
anti-HA antibody, and then FITC-conjugated goat anti-rabbit antibody and TRITC-conjugated anti-mouse antibody. The cells were
observed under an Olympus FV500 confocal microscope.
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Downregulation of Hrs improves HIV-1 production
To further determine whether Hrs inhibits citron kinase-
mediated HIV-1 production under physiological conditions,
Hrs levels were knocked down by RNA interference
(RNAi). Plasmids expressing short hairpin RNAs (shRNAs)
directed against different sequences of Hrs (Hrsi4 and
Hrsi5) were transfected into HEK293T cells with the HIV-1
vector-producing constructs with or without citron kinase,
and HIV-1 production efficiency was measured. The ability
of the shRNAs to downregulate the expression of Hrs
was first confirmed (Fig. 4A). Downregulation of Hrs
reproducibly increased HIV production by ~2-fold (Fig. 4B;
columns 3 and 5). Due to different experimental settings,
the enhancement of HIV-1 production by the overexpression
of citron kinase was not as significant as described above,
i.e., only approximately 3-fold (Fig. 4B; column 2). In any
event, the downregulation of Hrs augmented citron kinase-
mediated enhancement of HIV-1 production (Fig. 4B;
columns 4 and 6).
DISCUSSION
We previously demonstrated that citron kinase is essential
for promoting HIV-1 budding by enhancing exocytosis
(Loomis et al., 2006). Here, we report that citron kinase
co-localizes with Hrs in early endosomes and MVBs by
confocal microscopy. The interaction between citron kinase
and Hrs was further confirmed by co-immunoprecipitation
assays. Overexpression of Hrs and its FYVE domain
attenuated citron kinase-mediated HIV-1 virion production,
while depletion of Hrs enhanced HIV-1 production and
augmented citron kinase-mediated enhancement of
HIV-1 production. Hrs interacts with citron kinase via its
FYVE domain. Expression of the Hrs FYVE domain alone
displayed a significant inhibitory effect on citron kinase-
mediated HIV-1 production. In contrast, Hrs6FYVE, an
Hrs mutant in which the FYVE domain is deleted, displayed
a much weaker effect on citron kinase-mediated HIV-1
production than full-length Hrs or its FYVE domain alone.
Collectively, these results indicate that the FYVE domain
is important for the inhibitory effect of Hrs on HIV-1
production.
Hrs and its isoform Hrs-2 play a negative role in exocytosis
(Bean et al., 1997; Kwong et al., 2000). Citron kinase
augments HIV-1 production by enhancing cellular exocytosis.
Depletion of Hrs by RNAi facilitated citron kinase-mediated
enhancement of HIV-1 production, suggesting that the
inhibitory effect of Hrs on HIV-1 production occurs via
endogenous citron kinase. Our results suggest that Hrs
inhibits exocytosis by interacting with citron kinase, providing
insight into the mechanism by which Hrs inhibits citron kinase-
mediated HIV-1 production. It should be noted that although
the virus production experiments were conducted in HEK
293T cells, our conclusions should be general. Indeed, it has
been demonstrated in previous reports that HIV-1 uses the
same budding pathways in T cells, HeLa cells, and HEK 293
cells (Ono and Freed, 2004; Dong et al., 2005; Finzi et al.,
2007; Perez-Caballero et al., 2009).
In summary, our results indicate that Hrs interacts with
citron kinase via its FYVE domain, and Hrs acts as an inhibitor
of citron kinase-mediated HIV-1 virion production.
Figure 2. Hrs interacts with citron kinase. (A) HEK293T
cells transfected with plasmids expressing myc-tagged citron
kinase (citK) and Flag-tagged Hrs were lysed in CoIP buffer.
The lysates were immunoprecipitated with anti-myc antibody,
and detected by Western blotting using anti-Flag antibody. (B)
HEK293T cells transfected with plasmids expressing myc-
tagged citK and FYVE-GFP were lysed in CoIP buffer. The
lysates were immunoprecipitated with anti-myc antibody, and
detected by Western blotting using anti-GFP antibody.
© Higher Education Press and Springer-Verlag Berlin Heidelberg 2011 473
Hrs inhibits citron kinase-mediated HIV-1 budding Protein & Cell
MATERIALS AND METHODS
Plasmids and cell lines
The plasmids pCMV-VSVG, pNL4-3-luc, and pCMV-renilla have
previously been described (Mai and Gao, 2010). Plasmids pCAG,
pCAG/citron kinase, pKU-Hrs, and pKU-HrsdFYVE have also been
described previously (Loomis et al., 2006; Bouamr et al., 2007). To
generate shRNAs directed against Hrs, oligonucleotides were
annealed and cloned into pSuper.retro-puro using the BamHI and
HindIII sites. The sequences of the oligos are listed below: Hrs
RNAi-4: 5′-GATCCCCAAGTGGAGGTAAACGTCCGTATTCAAGA-
GATACGGACGTTTACCTCCACTTTTTTTA-3′ (forward) and 5′-
AGCTTAAAAAAAGTGGAGGTAAACGTCCGTATCTCTTGAATACG-
GACGTTTACCTCCACTTGGG-3′ (reverse); Hrs RNAi-5: 5′-
GATCCCCAGGTAAACGTCCGTAACAATTCAAGAGATTGTTACG-
GACGTTTACCTTTTTTA-3′ (forward) and 5′-AGCTTAAAAAAGG-
TAAACGTCCGTAACAATCTCTTGAATTGTTACGGACGTT-
TACCTGGG-3′(reverse).
All the cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum at 37°C
and 5% CO2. Transfections were performed by either calcium
phosphate precipitation or polyethylenimine transfection.
Immunofluorescence microscopy
HeLa cells were grown on coverslips, fixed in 4% paraformaldehyde,
permeabilized in 0.4% Triton X-100, and incubated with primary and
secondary antibodies. The primary antibody was either 1:500 anti-
myc (mouse monoclonal, Sigma) or 1:200 anti-citron (rabbit
polyclonal). The secondary antibody was TRITC-conjugated anti-
mouse IgG, FITC-conjugated anti-mouse IgG, or FITC-conjugated
goat anti-rabbit IgG (Sigma). The coverslips were mounted onto
slides, and fluorescence images were acquired under an Olympus
FV500 confocal fluorescence microscope.
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Figure 3. Overexpression of Hrs inhibits citK-mediated HIV-1production. The plasmids expressing the indicated proteins
were cotransfected into HEK293T cells with the HIV-1 pseudovirus-producing constructs (pNL4-3luc and pVSVG), and pCMV-
renilla, which expresses renilla luciferase and served as a control for transfection efficiency and sample handling. At 48 h post-
transfection, the HIV-1 pseudovirus was harvested to infect HeLa cells. The luciferase activities were measured in the producer
HEK293T cells and the recipient HeLa cells. The firefly luciferase activity in the producer cells was normalized by the renilla
luciferase activity. Relative virus production was calculated as the luciferase activity in HeLa cells divided by the normalized
luciferase activity in HEK293T cells. The data are means ± standard error of three independent measurements.
Figure 4. Depletion of Hrs increases HIV-1 production and
facilitates citK-mediated HIV-1 production. The HIV vector-
producing constructs (pNL4-3luc and pVSVG) were cotrans-
fected into HEK293T cells with the plasmid expressing citron
kinase, the plasmid expressing shRNA directed against Hrs
(Hrsi4 and Hrsi5), and pCMV-renilla, which expressed renilla
luciferase and served as a control for transfection efficiency and
sample handling. At 48 h post-transfection, the HIV-1 pseudo-
virus was harvested to infect recipient HeLa cells. The luciferase
activities were measured in the producer HEK293Tcells and the
recipient HeLa cells. The firefly luciferase activity in the producer
cells was normalized by the renilla luciferase activity. Relative
virus production was calculated as the luciferase activity in HeLa
cells divided by the normalized luciferase activity in HEK293T
cells. The data are means ± standard error of three independent
measurements. *p< 0.05.
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Co-immunoprecipitation assays
Transfected HEK293T cells were lysed 48 h post-transfection with
CoIP buffer (50mmol/LTris-HCl (pH 7.5), 150mmol/L NaCl, and 0.5%
NP-40) supplemented with a protease inhibitor cocktail. The lysates
were clarified by centrifugation at 4°C for 10 min at 13,000 rpm. The
supernatant was mixed with protein G plus-agarose (Santa Cruz
Biotechnology) and the indicated antibodies and then incubated at
4°C for 2 h. The resins were washed 3–4 times with CoIP buffer, and
the bound proteins were detected by Western blotting.
Infection assays
HEK293T cells were seeded in 6-well plates and transfected with
pNL4-3luc and pCMV-VSVG to generate HIV-1 vector NL4-3-luc. At
48 h post-transfection, the supernatants were harvested. HeLa cells
were seeded in 12-well plates and infected with the NL4-3-luc virus for
3 h, and then the infection medium was replaced with fresh medium.
At 48 h post-infection, the cells were lysed, and luciferase activities
were measured.
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